Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
22,3 NOK | -2,62% | -0,89% | -4,29% |
Omzet 2021 | 279 mln. 25,63 mln. 23,76 mln. | Omzet 2022 | 305 mln. 28,05 mln. 26 mln. | Marktkapitalisatie | 701 mln. 64,46 mln. 59,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 24 mln. 2,21 mln. 2,05 mln. | Nettowinst (verlies) 2022 | -4 mln. -368K -341K | EV/omzet 2021 | 2,96 x |
Nettoliquiditeiten 2021 | 34,36 mln. 3,16 mln. 2,93 mln. | Nettoschuld 2022 | 47,73 mln. 4,39 mln. 4,07 mln. | EV/omzet 2022 | 2,45 x |
K/w-verhouding 2021 |
34,6
x | K/w-verhouding 2022 |
-144
x | Werknemers | 78 |
Dividendrendement 2021 |
3,87% | Dividendrendement 2022 |
4,75% | Vrij verhandelbaar | 44,15% |
Recentste transcriptie over Vistin Pharma ASA
1 dag | -2,62% | ||
1 week | -0,89% | ||
Lopende maand | -1,76% | ||
3 maanden | -3,04% | ||
6 maanden | -7,08% | ||
Lopend jaar | -4,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-03-20 | |
Director of Finance/CFO | - | 02-03-20 | |
Eivind Egeli
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 76 | 01-06-20 | |
Director/Board Member | 62 | 06-03-15 | |
Director/Board Member | 60 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 22,3 | -2,62% | 8 451 |
26-03-24 | 22,9 | +1,33% | 2 308 |
25-03-24 | 22,6 | +2,26% | 530 520 |
22-03-24 | 22,1 | -1,78% | 1 300 |
21-03-24 | 22,5 | -1,32% | 3 446 |
Real Time Oslo Bors, 27 maart 2024 om 14:20 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-4,29% | 91,23 mln. | |
+28,67% | 46,63 mld. | |
+19,30% | 22,49 mld. | |
+20,11% | 14,49 mld. | |
+0,55% | 12,98 mld. | |
+46,16% | 12,16 mld. | |
-2,44% | 7,69 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+7,80% | 5,15 mld. |